Investigation of non-V600 BRAF mutations commonly found in NSCLC for their sensitivity to dabrafenib or trametinib.

Amir Noeparast, Gil Verschelden, Ijeoma Umelo, Sylvia De Brakeleer, Lore Decoster, Erik Teugels, Jacques De Greve

Research output: Contribution to journal › Meeting abstract (Journal)

Original language	English
Pages (from-to)	11091
Journal	Journal of Clinical Oncology
Volume	33
Issue number	15
Publication status	Published - 20 May 2015
Event	Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duration: 29 May 2015 → 2 Jun 2015

Handle.net

@article{a9cd19fb6ac24f868c03a5504c15240c,

title = "Investigation of non-V600 BRAF mutations commonly found in NSCLC for their sensitivity to dabrafenib or trametinib.",

author = "Amir Noeparast and Gil Verschelden and Ijeoma Umelo and {De Brakeleer}, Sylvia and Lore Decoster and Erik Teugels and {De Greve}, Jacques",

year = "2015",

month = may,

day = "20",

language = "English",

volume = "33",

pages = "11091",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "Annual Meeting of the American Society of Clinical Oncology (ASCO) ; Conference date: 29-05-2015 Through 02-06-2015",

}

TY - JOUR

T1 - Investigation of non-V600 BRAF mutations commonly found in NSCLC for their sensitivity to dabrafenib or trametinib.

AU - Noeparast, Amir

AU - Verschelden, Gil

AU - Umelo, Ijeoma

AU - De Brakeleer, Sylvia

AU - Decoster, Lore

AU - Teugels, Erik

AU - De Greve, Jacques

PY - 2015/5/20

Y1 - 2015/5/20

M3 - Meeting abstract (Journal)

SN - 0732-183X

VL - 33

SP - 11091

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

T2 - Annual Meeting of the American Society of Clinical Oncology (ASCO)

Y2 - 29 May 2015 through 2 June 2015

ER -